LI
BXRX

Leap Investments’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Leap Investments’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$79K Buy
+14
New +$67.2K 0.05% 364

Other funds holding BXRX

NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Leap Investments's BXRX Position: Q2 2020 in Review

Leap Investments opened a new position in Baudax Bio, Inc. Common Stock (BXRX) in Q2 2020: 14 shares worth $79K. The stake represents 0.05% of the portfolio and ranks #364 among its holdings.

38 funds tracked by Wall St. Rank hold BXRX as of Q2 2020.

  • Leap Investments held 14 shares of Baudax Bio, Inc. Common Stock worth $79K as of Q2 2020.
  • Baudax Bio, Inc. Common Stock was a new Leap Investments position in Q2 2020.
  • Baudax Bio, Inc. Common Stock made up 0.05% of Leap Investments's portfolio in Q2 2020, its #364 holding.
  • 38 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.